LEADER 01087nam  2200361   450 
001 9910715906203321
005 20211228155453.0
035   $a(CKB)5470000002517037
035   $a(OCoLC)1290257380
035   $a(EXLCZ)995470000002517037
100   $a20211228d2018      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aInsulin
210  1$a[Silver Spring, Md.] :$cFDA Office of Women's Health,$d2018.
215   $a1 online resource (12 pages) $cillustrations
517   $aInsulin 
606   $aInsulin$xTherapeutic use
606   $aInsulin$xTherapeutic use$xAdministration
606   $aDiabetes$xTreatment
615  0$aInsulin$xTherapeutic use.
615  0$aInsulin$xTherapeutic use$xAdministration.
615  0$aDiabetes$xTreatment.
712 02$aUnited States.$bFood and Drug Administration.$bOffice of Women's Health,
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910715906203321
996   $aInsulin$91891313
997   $aUNINA